| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |